George leads our regulatory and clinical affairs, bringing over 20 years of experience developing regulated products and compounds across various areas of FDA, including CBER, CDER and CDRH leading to 13 products reaching regulatory, commercial or academic exits. Prior to joining physIQ, George was Managing Partner at Geis-Hides Consulting, a boutique clinical and regulatory consultancy serving early stage biotech and pharmaceutical companies across various therapeutic areas. He served as VP of Clinical Development and Regulatory Affairs at Northfield Laboratories Inc, where he led the development of PolyHeme®, a first-in-class novel hemoglobin-based oxygen carrier (HBOC) as a blood substitute for use in hemorrhagic shock following trauma. George contributed to extensive policy-developing interactions with the FDA for the study of trauma, he filed more than 50 Emergency Use INDs, and he is an author of several clinical manuscripts in HBOCs and resuscitation. In academia, George is an instructor in the Department of Medical Physics at Rush University and serves on the academic advisory board. George earned his BA in Physics from DePauw University.